+265 997 788 370
Lesson Uncertainty in AstraZeneca vaccine supplies due to limited global supply was well managed in Botswana.
Date 16th July, 2021
Country Botswana
Category Success
Theme Supply chain and logistics
Impact Globally, COVID-19 vaccine demand is relatively high compared to supply. In its press release on 16th July 2021, the ministry of Heath and wellness of Botswana notified the public on the delayed arrival of AstraZeneca vaccine which was supposed to be used for second dosing, owing to high global demand for this vaccine regimen. The supplier delayed to meet expected delivery deadline. Due to this shortage, those affected were to be offered Mordena or Pfizer vaccine regimens for their second dosing. This ensured smooth deployment of vaccination efforts.
Recommendation It is clear that a pandemic affects all countries globally and vaccine supply chain is a very complex task. Countries should well prepare by having multiple vaccine sources to help achieve their vaccination goals, particularly that the demand for vaccination is relatively high compared to supply. There is evidence of known high efficacy and safety profile of mixed vaccine regimens. Importantly, training health workers on how to administer mix and match doses in the case of supply imbalances can ensure effective vaccine delivery.